Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Migraine

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 60 articles:
HTML format
Text format



Single Articles


    August 2019
  1. ZIEGELER C, May A
    Facial presentations of migraine, TACs, and other paroxysmal facial pain syndromes.
    Neurology. 2019 Aug 21. pii: WNL.0000000000008124.
    PubMed     Text format     Abstract available


  2. OSKOUI M, Pringsheim T, Holler-Managan Y, Potrebic S, et al
    Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Neurology. 2019 Aug 14. pii: WNL.0000000000008095.
    PubMed     Text format     Abstract available


  3. OSKOUI M, Pringsheim T, Billinghurst L, Potrebic S, et al
    Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Neurology. 2019 Aug 14. pii: WNL.0000000000008105.
    PubMed     Text format     Abstract available


  4. TEE TY, Khoo CS, Raymond AA, Syazarina SO, et al
    Teaching NeuroImages: Neuroimaging in hemiplegic migraine.
    Neurology. 2019;93:e626-e627.
    PubMed     Text format    


    July 2019
  5. VAN DONGEN RM, Waaijer LC, Onderwater GLJ, Ferrari MD, et al
    Treatment effects and comorbid diseases in 58 patients with visual snow.
    Neurology. 2019;93:e398-e403.
    PubMed     Text format     Abstract available


  6. ARKINK EB, Palm-Meinders IH, Koppen H, Milles J, et al
    Microstructural white matter changes preceding white matter hyperintensities in migraine.
    Neurology. 2019 Jul 11. pii: WNL.0000000000007940.
    PubMed     Text format     Abstract available


  7. FORD JH, Ayer DW, Zhang Q, Carter JN, et al
    Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability.
    Neurology. 2019 Jul 3. pii: WNL.0000000000007856.
    PubMed     Text format     Abstract available


    May 2019
  8. TU Y, Fu Z, Zeng F, Maleki N, et al
    Abnormal thalamo-cortical network dynamics in migraine.
    Neurology. 2019 May 10. pii: WNL.0000000000007607.
    PubMed     Text format     Abstract available


  9. COPPOLA G, Di Renzo A, Petolicchio B, Tinelli E, et al
    Aberrant interactions of cortical networks in chronic migraine: A resting-state fMRI study.
    Neurology. 2019 May 3. pii: WNL.0000000000007577.
    PubMed     Text format     Abstract available


    April 2019
  10. LIPTON RB, Tepper SJ, Reuter U, Silberstein S, et al
    Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study.
    Neurology. 2019 Apr 17. pii: WNL.0000000000007452.
    PubMed     Text format     Abstract available


  11. TEPPER SJ, Diener HC, Ashina M, Brandes JL, et al
    Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial.
    Neurology. 2019 Apr 17. pii: WNL.0000000000007497.
    PubMed     Text format     Abstract available


  12. ONDERWATER GLJ, Ligthart L, Bot M, Demirkan A, et al
    Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine.
    Neurology. 2019 Apr 3. pii: WNL.0000000000007313.
    PubMed     Text format     Abstract available


    March 2019
  13. ALBRECHT DS, Mainero C, Ichijo E, Ward N, et al
    Imaging of neuroinflammation in migraine with aura: A [(11)C]PBR28 PET/MRI study.
    Neurology. 2019 Mar 27. pii: WNL.0000000000007371.
    PubMed     Text format     Abstract available


  14. FILIPPI M, Messina R, Goadsby PJ, Rocca MA, et al
    Author response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2019;92:587-588.
    PubMed     Text format    


  15. GUPTA VK
    Reader response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2019;92:587.
    PubMed     Text format    


  16. SIEGLER JE 3RD, Galetta S
    Editors' note: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2019;92:586.
    PubMed     Text format    


  17. LAPUCCI C, Saitta L, Bommarito G, Sormani MP, et al
    How much do periventricular lesions assist in distinguishing migraine with aura from CIS?
    Neurology. 2019 Mar 8. pii: WNL.0000000000007266.
    PubMed     Text format     Abstract available


    February 2019
  18. DOMINGUEZ C, Lopez A, Ramos-Cabrer P, Vieites-Prado A, et al
    Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2019 Feb 1. pii: WNL.0000000000007047.
    PubMed     Text format     Abstract available


    January 2019
  19. LEE MJ, Park BY, Cho S, Park H, et al
    Cerebrovascular reactivity as a determinant of deep white matter hyperintensities in migraine.
    Neurology. 2019 Jan 4. pii: WNL.0000000000006822.
    PubMed     Text format     Abstract available


    December 2018
  20. GELAYE B, Sacco S, Brown W, Nitchie H, et al
    Author response: Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2018;91:1074.
    PubMed     Text format    


  21. GUPTA VK
    Reader response: Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2018;91:1073.
    PubMed     Text format    


  22. LEWIS A, Galetta S
    Editors' note: Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2018;91:1073.
    PubMed     Text format    


    November 2018
  23. REISMAN AM, Robbins BT, Chou DE, Yugrakh MS, et al
    Ticagrelor for Refractory Migraine/Patent Foramen Ovale (TRACTOR): An open-label pilot study.
    Neurology. 2018;91:1010-1017.
    PubMed     Text format     Abstract available


  24. SOMMER RJ, Nazif T, Privitera L, Robbins BT, et al
    Retrospective review of thienopyridine therapy in migraineurs with patent foramen ovale.
    Neurology. 2018;91:1002-1009.
    PubMed     Text format     Abstract available


  25. DETKE HC, Goadsby PJ, Wang S, Friedman DI, et al
    Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study.
    Neurology. 2018 Nov 16. pii: WNL.0000000000006640.
    PubMed     Text format     Abstract available


  26. KUCA B, Silberstein SD, Wietecha L, Berg PH, et al
    Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.
    Neurology. 2018 Nov 16. pii: WNL.0000000000006641.
    PubMed     Text format     Abstract available


  27. FRIDMAN S, Sposato LA
    Migraine with visual aura, incident AF, and stroke risk: Is migraine with aura an embolic TIA?
    Neurology. 2018 Nov 14. pii: WNL.0000000000006637.
    PubMed     Text format    


  28. SEN S, Androulakis XM, Duda V, Alonso A, et al
    Migraine with visual aura a risk factor for incident atrial fibrillation: A cohort study.
    Neurology. 2018 Nov 14. pii: WNL.0000000000006650.
    PubMed     Text format     Abstract available


    August 2018
  29. VEREB D, Szabo N, Tuka B, Tajti J, et al
    Correlation of neurochemical and imaging markers in migraine: PACAP38 and DTI measures.
    Neurology. 2018 Aug 22. pii: WNL.0000000000006201.
    PubMed     Text format     Abstract available


  30. VANDERPLUYM J, Dodick DW, Lipton RB, Ma Y, et al
    Fremanezumab for preventive treatment of migraine: Functional status on headache-free days.
    Neurology. 2018 Aug 17. pii: 01.wnl.0000544321.19316.
    PubMed     Text format     Abstract available


    June 2018
  31. VAN OOSTERHOUT WPJ, Schoonman GG, van Zwet EW, Dekkers OM, et al
    Female sex hormones in men with migraine.
    Neurology. 2018 Jun 27. pii: WNL.0000000000005855.
    PubMed     Text format     Abstract available


  32. MESSINA R, Rocca MA, Colombo B, Pagani E, et al
    Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2018 Jun 20. pii: WNL.0000000000005819.
    PubMed     Text format     Abstract available


  33. TASSORELLI C, Grazzi L, de Tommaso M, Pierangeli G, et al
    Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study.
    Neurology. 2018 Jun 15. pii: WNL.0000000000005857.
    PubMed     Text format     Abstract available


  34. LIPTON RB, Goadsby PJ
    Comment: Noninvasive neurostimulation for migraine should be part of the general neurologist's therapeutic armamentarium.
    Neurology. 2018 Jun 15. pii: WNL.0000000000005870.
    PubMed     Text format    


    April 2018
  35. SCHULTE LH, Allers A, May A
    Visual stimulation leads to activation of the nociceptive trigeminal nucleus in chronic migraine.
    Neurology. 2018 Apr 27. pii: WNL.0000000000005622.
    PubMed     Text format     Abstract available


    March 2018
  36. EL YOUSSEF N, Maalouf N, Mourad A, Saade J, et al
    Teaching NeuroImages: Retinal migraine in action.
    Neurology. 2018;90:e992.
    PubMed     Text format    


    January 2018
  37. PELZER N, Haan J, Stam AH, Vijfhuizen LS, et al
    Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation.
    Neurology. 2018 Jan 17. pii: WNL.0000000000004966.
    PubMed     Text format     Abstract available


    November 2017
  38. KOWALEC K, McKay KA, Patten SB, Fisk JD, et al
    Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.
    Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004716.
    PubMed     Text format     Abstract available


    October 2017
  39. FRIEDMAN BW, Irizarry E, Solorzano C, Latev A, et al
    Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine.
    Neurology. 2017 Oct 18. pii: 10.1212/WNL.0000000000004642.
    PubMed     Text format     Abstract available


  40. PALM-MEINDERS IH, Arkink EB, Koppen H, Amlal S, et al
    Volumetric brain changes in migraineurs from the general population.
    Neurology. 2017 Oct 11. pii: 10.1212/WNL.0000000000004640.
    PubMed     Text format     Abstract available


    August 2017
  41. FERRONI P, Barbanti P, Aurilia C, Egeo G, et al
    Procoagulant imbalance in premenopausal women with chronic migraine.
    Neurology. 2017 Aug 25. pii: 10.1212/WNL.0000000000004435.
    PubMed     Text format    


  42. ASHINA M, Dodick D, Goadsby PJ, Reuter U, et al
    Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study.
    Neurology. 2017 Aug 23. pii: 10.1212/WNL.0000000000004391.
    PubMed     Text format     Abstract available


  43. BEAR JJ, Gelfand AA, Goadsby PJ, Bass N, et al
    Occipital headaches and neuroimaging in children.
    Neurology. 2017;89:469-474.
    PubMed     Text format     Abstract available


    July 2017
  44. MULLER KI, Alstadhaug KB, Bekkelund SI
    A randomized trial of telemedicine efficacy and safety for nonacute headaches.
    Neurology. 2017;89:153-162.
    PubMed     Text format     Abstract available


  45. SCHER AI, Buse DC, Fanning KM, Kelly AM, et al
    Comorbid pain and migraine chronicity: The Chronic Migraine Epidemiology and Outcomes Study.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004177.
    PubMed     Text format     Abstract available


    June 2017
  46. ANDROULAKIS XM, Krebs K, Peterlin BL, Zhang T, et al
    Modulation of intrinsic resting-state fMRI networks in women with chronic migraine.
    Neurology. 2017 Jun 14. pii: 10.1212/WNL.0000000000004089.
    PubMed     Text format     Abstract available


  47. DE JONG HJI, Kingwell E, Shirani A, Cohen Tervaert JW, et al
    Evaluating the safety of beta-interferons in MS: A series of nested case-control studies.
    Neurology. 2017;88:2310-2320.
    PubMed     Text format     Abstract available


    April 2017
  48. SCHULTE LH, Allers A, May A
    Hypothalamus as a mediator of chronic migraine: Evidence from high-resolution fMRI.
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003963.
    PubMed     Text format     Abstract available


  49. GELAYE B, Sacco S, Brown WJ, Nitchie HL, et al
    Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2017 Apr 12. pii: 10.1212/WNL.0000000000003919.
    PubMed     Text format     Abstract available


    March 2017
  50. DASILVA AF, Nascimento TD, Jassar H, Heffernan J, et al
    Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003861.
    PubMed     Text format     Abstract available


  51. MONTEITH TS
    Migraine relief: Nonpainful stimulation for acute attacks.
    Neurology. 2017;88:e128-e131.
    PubMed     Text format    


  52. YARNITSKY D, Volokh L, Ironi A, Weller B, et al
    Nonpainful remote electrical stimulation alleviates episodic migraine pain.
    Neurology. 2017 Mar 1. pii: 10.1212/WNL.0000000000003760.
    PubMed     Text format     Abstract available


    December 2016
  53. ANDROULAKIS XM, Kodumuri N, Giamberardino LD, Rosamond WD, et al
    Ischemic stroke subtypes and migraine with visual aura in the ARIC study.
    Neurology. 2016;87:2527-2532.
    PubMed     Text format     Abstract available


  54. SPOSATO LA, Peterlin BL
    Cardioembolism as the unsuspected missing link between migraine and ischemic stroke.
    Neurology. 2016;87:2504-2505.
    PubMed     Text format    


    November 2016
  55. SETHI M, Kowalczyk MA, Dalic LJ, Archer JS, et al
    Abnormal neurovascular coupling during status epilepticus migrainosus in Sturge-Weber syndrome.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003492.
    PubMed     Text format    


  56. LOUTER MA, Pelzer N, de Boer I, Kuijvenhoven BE, et al
    Prevalence of lifetime depression in a large hemiplegic migraine cohort.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003376.
    PubMed     Text format     Abstract available


    October 2016
  57. DESOUZA DD, O'Hare M, Woldeamanuel YW, Cowan RP, et al
    Journal Club: Change in brain network connectivity during PACAP38-induced migraine attacks.
    Neurology. 2016;87:e199-e202.
    PubMed     Text format    


  58. WOLDEAMANUEL YW, O'Hare M, DeSouza DD, Cowan RP, et al
    Journal Club: Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome.
    Neurology. 2016;87:e196-e198.
    PubMed     Text format     Abstract available


  59. COPPOLA G, Di Renzo A, Tinelli E, Di Lorenzo C, et al
    Thalamo-cortical network activity during spontaneous migraine attacks.
    Neurology. 2016 Oct 14. pii: 10.1212/WNL.0000000000003327.
    PubMed     Text format     Abstract available


  60. VERSLEGERS WR, Leone M, Proietti Cecchini A
    Long-term use of daily sumatriptan injections in severe drug-resistant chronic cluster headache.
    Neurology. 2016;87:1522-1523.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: